Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034291704> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W2034291704 endingPage "215" @default.
- W2034291704 startingPage "215" @default.
- W2034291704 abstract "Adjunctive blockade of the platelet glycoprotein (GP) IIb/IIIa receptor during either percutaneous coronary intervention (PCI) or for patients who present with non-ST segment elevation acute coronary syndromes has demonstrated efficacy in reducing platelet-mediated adverse cardiovascular ischemic events. The three currently available agents (abciximab, eptifibatide, tirofiban) differ markedly in pharmacodynamic and pharmacokinetic profiles, receptor affinity, and cost. Although pharmacoeconomic substudies are available from placebo-controlled randomized trials of platelet GPIIb/IIIa blockade during PCI, “real-world” cost-effectiveness data from high-volume practice are lacking. Therefore, in-hospital and late (6-month) clinical outcomes and cumulative cost/charge data were analyzed on 1472 consecutive PCI procedures (70% received abciximab) performed by high-volume operators at a single institution.1 Data were adjusted for lack of randomized treatment allocation with the use of a propensity scoring technique. Adjunctive abciximab therapy for PCI was associated with a significant (3.4%) reduction in mortality to 6 months. Based on the economic cost-effectiveness concept of cost per life year gained relative to standard therapy,2, 3 abciximab provided a cost-effective survival advantage in high-volume interventional practice that compares very favorably with currently accepted standards. Clinical and procedural demographics associated with increased cost-effectiveness include multivessel coronary intervention, stent deployment, recent (<1 week) myocardial infarction (MI), and impaired left-ventricular (LV) function. (Am Heart J 2000;140:S148-53.)" @default.
- W2034291704 created "2016-06-24" @default.
- W2034291704 creator A5037745328 @default.
- W2034291704 creator A5048940765 @default.
- W2034291704 creator A5064573204 @default.
- W2034291704 creator A5070467170 @default.
- W2034291704 creator A5088962486 @default.
- W2034291704 date "2010-06-01" @default.
- W2034291704 modified "2023-10-18" @default.
- W2034291704 title "MS527 EVALUATION OF LIPID, INFLAMMATORY AND OXIDATIVE STRESS/ANTI-OXIDATIVE DEFENCE MARKERS FOR THE PREDICTION OF CARDIOVASCULAR RISK" @default.
- W2034291704 doi "https://doi.org/10.1016/s1567-5688(10)71027-8" @default.
- W2034291704 hasPublicationYear "2010" @default.
- W2034291704 type Work @default.
- W2034291704 sameAs 2034291704 @default.
- W2034291704 citedByCount "0" @default.
- W2034291704 crossrefType "journal-article" @default.
- W2034291704 hasAuthorship W2034291704A5037745328 @default.
- W2034291704 hasAuthorship W2034291704A5048940765 @default.
- W2034291704 hasAuthorship W2034291704A5064573204 @default.
- W2034291704 hasAuthorship W2034291704A5070467170 @default.
- W2034291704 hasAuthorship W2034291704A5088962486 @default.
- W2034291704 hasConcept C126322002 @default.
- W2034291704 hasConcept C164705383 @default.
- W2034291704 hasConcept C168563851 @default.
- W2034291704 hasConcept C2776335557 @default.
- W2034291704 hasConcept C2777849778 @default.
- W2034291704 hasConcept C2777871224 @default.
- W2034291704 hasConcept C2780400711 @default.
- W2034291704 hasConcept C2781056559 @default.
- W2034291704 hasConcept C45393284 @default.
- W2034291704 hasConcept C500558357 @default.
- W2034291704 hasConcept C71924100 @default.
- W2034291704 hasConceptScore W2034291704C126322002 @default.
- W2034291704 hasConceptScore W2034291704C164705383 @default.
- W2034291704 hasConceptScore W2034291704C168563851 @default.
- W2034291704 hasConceptScore W2034291704C2776335557 @default.
- W2034291704 hasConceptScore W2034291704C2777849778 @default.
- W2034291704 hasConceptScore W2034291704C2777871224 @default.
- W2034291704 hasConceptScore W2034291704C2780400711 @default.
- W2034291704 hasConceptScore W2034291704C2781056559 @default.
- W2034291704 hasConceptScore W2034291704C45393284 @default.
- W2034291704 hasConceptScore W2034291704C500558357 @default.
- W2034291704 hasConceptScore W2034291704C71924100 @default.
- W2034291704 hasIssue "2" @default.
- W2034291704 hasLocation W20342917041 @default.
- W2034291704 hasOpenAccess W2034291704 @default.
- W2034291704 hasPrimaryLocation W20342917041 @default.
- W2034291704 hasRelatedWork W103736013 @default.
- W2034291704 hasRelatedWork W2007033412 @default.
- W2034291704 hasRelatedWork W2058971526 @default.
- W2034291704 hasRelatedWork W2060231998 @default.
- W2034291704 hasRelatedWork W2163292105 @default.
- W2034291704 hasRelatedWork W2364471159 @default.
- W2034291704 hasRelatedWork W2411123120 @default.
- W2034291704 hasRelatedWork W2552017037 @default.
- W2034291704 hasRelatedWork W3105096449 @default.
- W2034291704 hasRelatedWork W1937835989 @default.
- W2034291704 hasVolume "11" @default.
- W2034291704 isParatext "false" @default.
- W2034291704 isRetracted "false" @default.
- W2034291704 magId "2034291704" @default.
- W2034291704 workType "article" @default.